1,209
Views
4
CrossRef citations to date
0
Altmetric
Research Article

From COPD epidemiology to studies of pathophysiological disease mechanisms: challenges with regard to study design and recruitment process

Respiratory and Cardiovascular Effects in COPD (KOLIN)

, ORCID Icon, ORCID Icon, , , ORCID Icon, , ORCID Icon, & show all
Article: 1415095 | Received 02 Nov 2017, Accepted 29 Nov 2017, Published online: 17 Dec 2017

References

  • Lundbäck B , Lindberg A , Lindström M , et al. Not 15 but 50% of smokers develop COPD?–report from the Obstructive Lung disease in Northern Sweden studies. Respir Med. 2003;97(2):1–8.
  • Jaganath D , Miranda JJ , Gilman RH , et al. Prevalence of chronic obstructive pulmonary disease and variation in risk factors across four geographically diverse resource-limited settings in Peru. Respir Res. 2015 Mar 18;16:40.
  • Backman H , Eriksson B , Rönmark E , et al. Decreased prevalence of moderate to severe COPD over 15 years in northern Sweden. Respir Med. 2016 May;114:103–110.
  • Lamprecht B , Soriano JB , Studnicka M , et al. Determinants of underdiagnosis of COPD in national and international surveys. Chest. 2015 Oct;148(4):971–985.
  • Danielsson P , Ólafsdóttir IS , Benediktsdóttir B , et al. The prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden–the burden of obstructive lung disease (BOLD) study: cross-sectional population-based study. Clin Respir J. 2012 Apr;6(2):120–127.
  • Kang MJ , Oh Y-M , Lee JC , et al. Lung matrix metalloproteinase-9 correlates with cigarette smoking and obstruction of airflow. J Korean Med Sci. 2003;18:821–827.
  • Brajer B , Batura-Gabryel H , Nowicka A , et al. Concentration of matrix Metalloproteinase-9 in serum of patients with chronic obstructive pulmonary disease and a degree of airway obstruction and disease progression. J Physiol Pharmacol. 2008;59:145–152.
  • Linder R , Rönmark E , Behndig A , et al. Serum MMP-9 is related to COPD severity and symptoms
- cross-sectional data from a population based cohort-study. Respir Res. 2015 Feb 21;16:28.
  • Weatherall M , Shirtcliffe P , Travers J , et al. Use of cluster analysis to define COPD phenotypes. Eur Respir J. 2010 Sep;36(3):472–474.
  • Lindberg A , Lundbäck B. The OLIN COPD study. Design, the first year participation and mortality. The Clin Respir J. 2008;2:64–71.
  • Vogelmeier CF , Criner GJ , Martinez FJ , et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lungdisease 2017 report: GOLD executive summary. Eur Respir J. 2017;49:1700214.
  • American Thoracic Society . Standardization of spirometry, 1994 update. Am J Respir Crit Care Med. 1995;152(3):1107–1136.
  • Berglund E , Birath G , Bjure J , et al. Spirometric studies in normal subjects. I. Forced expirograms in subjects between 7 and 70 years of age. Acta Med Scand. 1963 Feb;173:185–192.
  • Lundbäck B , Stjernberg N , Nyström L , et al. Epidemiology of respiratory symptoms, lung function and important determinants. Report from the obstructive lung disease in northern Sweden project. Tuber Lung Dis. 1994 Apr;75(2):116–126.
  • Matsson M , Söderhäll C , Einarsdottir E , et al. The C allele of rs8040868 in CHRNA3 is associated with chronic obstructive pulmonary disease and decreased CHRNA5 expression levels in lung tissue. BMC Pulm Med. 2016;16(1):146.
  • Lindberg A , Sawalha S , Hedman L , et al. Subjects with COPD and productive cough have an increased risk for exacerbations and death. Respir Med. 2015;109(1):88–95.
  • Lindberg A , Larsson LG , Ronmark E , et al. Co-morbidity in mild-to-moderate COPD: comparison to normal and restrictive lung function. COPD. 2011;8(6):421–428.
  • Qvist L , Nilsson U , Johansson V , et al. Central arterial stiffness is increased in subjects with severe and very severe COPD
- report from a population based cohort-study. Eur Clin Respir J. 2015;2:27023.
  • Nilsson U , Blomberg A , Johansson B , et al. Ischemic ECG abnormalities are associated with an increased risk for death among subjects with COPD, also among those without known heart disease. Int J Chron Obstruct Pulmon Dis. 2017 Aug 22;12:2507–2514.
  • Andersson M , Stridsman C , Rönmark E , et al. Physical activity and fatigue in chronic obstructive pulmonary disease – a population based study. Respir Med. 2015 Aug;109(8):1048–1057.
  • Strandkvist VJ , Backman H , Röding J , et al. Hand grip strength is associated with forced expiratory volume in 1 second among subjects with COPD: report from a population-based cohort study. Int J Chron Obstruct Pulmon Dis. 2016 Oct 7;11:2527–2534.
  • Stridsman C , Muellerova H , Skär L , et al. Fatigue in COPD and the impact of respiratory symptoms and heart disease – a population-based study. COPD. 2013 Apr;10(2):125–132.
  • Stridsman C , Lindberg A , Skär L. Fatigue in chronic obstructive pulmonary disease: a qualitative study of peoples experiences. Scand J Caring Sci. 2014 Mar;28(1):130–138.
  • Jansson SA , Backman H , Rönmark E , et al. Hospitalization due to co-morbid conditions is the main cost driver in COPD(- a report from the population based OLIN COPD study. COPD. 2015 Aug;12(4):381–389.
  • Vestbo J , Lange P. Natural history of COPD: focusing on change in FEV1. Respirology. 2016 Jan;21(1):34–43.
  • Vestbo J , Prescott E , Lange P . Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. Am J Respir Crit Care Med. 1996 May;153(5):1530–1535.
  • Fletcher C , Peto R . The natural history of chronic airflow obstruction. Br Med J. 1977 Jun 25;1(6077):1645–1648.
  • Bhatt SP , Soler X , Wang X , et al. Association between functional small airway disease and FEV1 decline in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2016 Jul 15;194(2):178–184.
  • Lindberg A , Larsson LG , Rönmark E , et al. Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms. COPD. 2007 Mar;4(1):5–13.
  • Koskela J , Katajisto M , Kallio A , et al. Individual FEV1 trajectories can be identified from a COPD cohort. COPD. 2016 Aug;13(4):425–430.
  • Lange P , Celli B , Agustí A , et al. Lung-function trajectories leading to chronic obstructive pulmonary disease. N Engl J Med. 2015 Jul 9;373(2):111–122.
  • Sanchez-Salcedo P , Divo M , Casanova C , et al. Disease progression in young patients with COPD: rethinking the Fletcher and Peto model. Eur Respir J. 2014 Aug;44(2):324–331.
  • Vestbo J , Edwards LD , Scanlon PD , et al. Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med. 2011 Sep 29;365(13):1184–1192.
  • Svanes C , Sunyer J , Plana E , et al. Early life origins of chronic obstructive pulmonary disease. Thorax. 2010 Jan;65(1):14–20.
  • Gershon AS , Mecredy GC , Guan J , et al. Quantifying comorbidity in individuals with COPD: a population study. Eur Respir J. 2015;45(1):51–59.
  • Löfdahl MJ , Roos-Engstrand E , Pourazar J , et al. Increased intraepithelial T-cells in stable COPD. Respir Med. 2008 Dec;102(12):1812–1818.
  • Forsslund H , Mikko M , Karimi R , et al. Distribution of T-cell subsets in BAL fluid of patients with mild to moderate COPD depends on current smoking status and not airway obstruction. Chest. 2014 Apr;145(4):711–722.
  • Hardie JA , Buist AS , Vollmer WM , et al. Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J. 2002 Nov;20(5):1117–1122.
  • Bakke PS , Rönmark E , Eagan T , et al. european respiratory society task force. Recommendations for epidemiological studies on COPD. Eur Respir J. 2011 Dec;38(6):1261–1277.
  • Celli BR , Halbert RJ , Isonaka S , et al. Population impact of different definitions of airway obstruction. Eur Respir J. 2003 Aug;22(2):268–273.
  • Lindberg A , Eriksson B , Larsson LG , et al. 7-year cumulative incidence of COPD in a general population sample. Chest. 2006;129:879–885.
  • Mannino DM , Buist AS , Petty TL , et al. Lung function and mortality in the USA: data from the First national health and nutrition examination survey follow up study. Thorax. 2003 May;58(5):388–393.
  • Jensen MT , Marott JL , Lange P , et al. Resting heart rate is a predictor of mortality in COPD. Eur Respir J. 2013 Aug;42(2):341–349.
  • Lange P , Çolak Y , Ingebrigtsen TS , et al. Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis. Lancet Respir Med. 2016 Jun;4(6):454–462.